Download PDFPDF
1231 A novel scoring system to predict PARP inhibitors efficacy in ovarian cancer patients undergoing neoadjuvant chemotherapy: findings from an Italian tertiary-care center
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address